What can we learn from the tortuous path to widespread clinical approval of the use of TMS therapy for depression?

Press/Media: Blogs, Podcasts and Social Media › Social Media Article

Period	22 Jun 2020

Media contributions

Title	What can we learn from the tortuous path to widespread clinical approval of the use of TMS therapy for depression.
Degree of recognition	National
Media type	Web
Country/Territory	Australia
Date	22/06/20
URL	https://www.linkedin.com/pulse/what-can-we-believe-the-hype-paul-fitzgerald/
Persons	Paul Fitzgerald